Over 30-35% of patients suffering from acute myeloid leukemia are due to mutations of FLT3‐ITD and FLT3‐TKD, consequently resulting in prolonged activation of protein that promotes cell proliferation and survival [135]. Here, FLT3 is linked to acute myeloid leukemia.